Thomas R. Sharp

514 total citations
28 papers, 325 citations indexed

About

Thomas R. Sharp is a scholar working on Spectroscopy, Molecular Biology and Organic Chemistry. According to data from OpenAlex, Thomas R. Sharp has authored 28 papers receiving a total of 325 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Spectroscopy, 6 papers in Molecular Biology and 4 papers in Organic Chemistry. Recurrent topics in Thomas R. Sharp's work include Mass Spectrometry Techniques and Applications (4 papers), Amino Acid Enzymes and Metabolism (3 papers) and Analytical Chemistry and Chromatography (3 papers). Thomas R. Sharp is often cited by papers focused on Mass Spectrometry Techniques and Applications (4 papers), Amino Acid Enzymes and Metabolism (3 papers) and Analytical Chemistry and Chromatography (3 papers). Thomas R. Sharp collaborates with scholars based in United States and United Kingdom. Thomas R. Sharp's co-authors include John E. Byfield, George D. Hegeman, George L. Kenyon, James F. Haw, Sallie S. Frankel, Cecil L. Hornbeck, Terrone L. Rosenberry, Stephen J. Benkovic, Robert M. Barone and Thomas N. Thomas and has published in prestigious journals such as Biochemistry, Cancer and Macromolecules.

In The Last Decade

Thomas R. Sharp

25 papers receiving 291 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas R. Sharp United States 12 71 64 63 61 58 28 325
Martin Wenzel Germany 15 147 2.1× 30 0.5× 62 1.0× 59 1.0× 68 1.2× 84 724
K.H. Kwan United States 8 111 1.6× 57 0.9× 23 0.4× 75 1.2× 35 0.6× 11 372
Dongying Chen China 12 209 2.9× 38 0.6× 85 1.3× 72 1.2× 25 0.4× 35 511
Laura J. Crane United States 13 239 3.4× 53 0.8× 195 3.1× 30 0.5× 54 0.9× 18 528
Linfeng Chen China 12 166 2.3× 34 0.5× 22 0.3× 78 1.3× 27 0.5× 18 380
N. V. B. Marsden Sweden 11 73 1.0× 23 0.4× 112 1.8× 14 0.2× 38 0.7× 28 322
S. Venkataram Canada 12 93 1.3× 60 0.9× 38 0.6× 44 0.7× 3 0.1× 21 363
P. Heitmann Germany 15 211 3.0× 45 0.7× 95 1.5× 35 0.6× 200 3.4× 39 677
Francesco Bartoli Italy 11 82 1.2× 48 0.8× 64 1.0× 82 1.3× 26 0.4× 43 317
Toshihiro Nishina Japan 13 256 3.6× 24 0.4× 45 0.7× 12 0.2× 59 1.0× 32 510

Countries citing papers authored by Thomas R. Sharp

Since Specialization
Citations

This map shows the geographic impact of Thomas R. Sharp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas R. Sharp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas R. Sharp more than expected).

Fields of papers citing papers by Thomas R. Sharp

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas R. Sharp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas R. Sharp. The network helps show where Thomas R. Sharp may publish in the future.

Co-authorship network of co-authors of Thomas R. Sharp

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas R. Sharp. A scholar is included among the top collaborators of Thomas R. Sharp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas R. Sharp. Thomas R. Sharp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sharp, Thomas R., et al.. (2024). Teaching Ultrasound-Guided Venous Cannulation to Newly Qualified Doctors. Cureus. 16(4). e58295–e58295.
2.
Sharp, Thomas R.. (2011). Calculated carbon–hydrogen bond dissociation enthalpies for predicting oxidative susceptibility of drug substance molecules. International Journal of Pharmaceutics. 418(2). 304–317. 14 indexed citations
3.
Sharp, Thomas R., et al.. (2008). New evidence for an impact origin of Taihu lake, China: Possible trigger of the extinction of LiangChu Culture 4500 years ago. AGU Fall Meeting Abstracts. 2008. 3 indexed citations
4.
Sharp, Thomas R.. (2007). The Presentation in the Temple. 1 indexed citations
5.
Blanchard, Andrew P., Beverly Nickerson, Linda Lohr, et al.. (2004). Identification of low-level degradants from low dose tablets. Journal of Pharmaceutical and Biomedical Analysis. 36(2). 265–275. 4 indexed citations
6.
Alsante, Karen M., Michel Couturier, Robert C. Friedmann, et al.. (2004). Pharmaceutical impurity identification: A case study using a multidisciplinary approach. Journal of Pharmaceutical Sciences. 93(9). 2296–2309. 33 indexed citations
7.
Likar, Michael D., et al.. (2003). Sertraline ( )-Lactate: Comprehensive Profile. PubMed. 30. 185–234. 1 indexed citations
8.
Sharp, Thomas R., et al.. (2003). On the photoisomerization of the benzisothiazole portion of ziprasidone. Tetrahedron Letters. 44(8). 1559–1561. 10 indexed citations
9.
Kramp, William, et al.. (1996). Evaluation of a two-site immunoradiometric assay for measuring noncomplexed (free) prostate-specific antigen. Clinical Chemistry. 42(8). 1243–1249. 12 indexed citations
10.
Sharp, Thomas R.. (1993). Sacrospinous suspension made easy.. PubMed. 82(5). 873–5. 24 indexed citations
11.
Lloyd, Kate, et al.. (1993). A twisted pentacyclic ketone derivative. Acta Crystallographica Section C Crystal Structure Communications. 49(2). 261–263.
12.
Sharp, Thomas R., et al.. (1991). Thermal degradation chemistry of poly(diphenoxyphosphazene). Macromolecules. 24(10). 2794–2799. 38 indexed citations
13.
Byfield, John E., et al.. (1985). Phase I and pharmacologic study of 72-hour infused 5-fluorouracil in man. American Journal of Clinical Oncology. 8(5). 429–440. 15 indexed citations
14.
Byfield, John E., et al.. (1985). Phase I and pharmacologic study of 72-hour infused 5-fluorouracil and hyperfractionated cyclical radiation. International Journal of Radiation Oncology*Biology*Physics. 11(4). 791–800. 38 indexed citations
15.
Sharp, Thomas R. & Terrone L. Rosenberry. (1985). Ionic strength dependence of the inhibition of acetylcholinesterase activity by Al3+. Biophysical Chemistry. 21(3-4). 261–264. 5 indexed citations
16.
Sharp, Thomas R. & Terrone L. Rosenberry. (1982). A pseudo-first-order kinetic approach to measurement of acetylcholine hydrolysis by acetylcholinesterase. Journal of Biochemical and Biophysical Methods. 6(2). 159–172. 12 indexed citations
17.
Seagren, Stephen L., John E. Byfield, Terence M. Davidson, & Thomas R. Sharp. (1982). Bleomycin, cyclophosphamide and radiotherapy in regionally advanced epidermoid carcinoma of the head and neck. International Journal of Radiation Oncology*Biology*Physics. 8(1). 127–132. 7 indexed citations
18.
Barone, Robert M., Paula M. Calabro-Jones, Thomas N. Thomas, Thomas R. Sharp, & John E. Byfield. (1981). Surgical adjuvant therapy in colon carcinoma: A human tumor spheroid model for evaluating radiation sensitizing agents. Cancer. 47(10). 2349–2357. 18 indexed citations
19.
Sharp, Thomas R., George D. Hegeman, & George L. Kenyon. (1977). Mandelate racemase from Pseudomonas putida. Absence of detectable intermolecular proton transfer accompanying racemization. Biochemistry. 16(6). 1123–1128. 10 indexed citations
20.
Sharp, Thomas R., et al.. (1953). Design in town and village. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026